Directory → Wegetotropona funds → Holinoliticaskie funds → M-holinolitiki → Berodual
This page is translated automatically with a help of Google Translate

Berodual

See also Belladonna

Roman name

Berodual

Farmakodinamika

Relaxes smooth muscles bronchus is stabilize membranes fat cells and bazofilov (reduced release of biologically active substances), improves mukotiliarnyi Cl.

Indications

Prevention and treatment of symptoms of chronic obstructive respiratory disease with reversible bronhospazmom : bronchial asthma, chronic bronchitis obstruguy, oslojnenny neoslojnenny or emphysema.

Pregnancy and lactation

Contraindicated in the first trimester of pregnancy. Be wary when using breast вскармливании.Необхо��имо consider inhibiting effect Beroduala ® H-Oxytocics activity of the uterus.

Contraindications

Hypersensitivity, gipertrofica obstructive cardiomyopathy, tahiaritmia, pregnancy (I term).

Specific guidance

The first application of a new form of measured aerosol Berodual ® H patients may note that the taste new product differs slightly from the same pharmaceutical form containing freon. The transition from one form to another, patients must be warned of a possible change in the taste sensations. It is also reported that these drugs interchangeably, and that the taste not related to the safety and efficacy of new drugs.

Patient interaction

Beta-adrainergicakie and antiholinergicakie means xantinove derivatives (theofillin) can enhance bronhorasshiratee effect. The simultaneous appointment of other beta-adrainomimetikov entering the systemic blood antiholinergicakih or xantinovykh derivative (eg theofillina) can be increased by Effectov.vozmozhno significant weakening of bronhorasshiratego while appointment бета-адреноблокаторо��.Одновременное with the use of MAO inhibitors and tricyclic antidepressants aggravating Beroduala ® Inhalation N. halogenated hydrocarbon anesthetics (alothane trichloroethylene, anfluran) may exacerbate the effects Beroduala ® H cardiovascular Sistemu.na backdrop of Beroduala ® H may gipokaliemii development, which could increase, while a xantinovykh derivatives, steroids and dioretikov. This fact should be given special attention in the treatment of patients with severe obstructive respiratory diseases Putei.gipokaliemia can lead to increased risk of arrhythmias in patients receiving digoxin. Furthermore, hypoxia may exacerbate the negative impact on gipokaliemii heart rhythm. In such cases, encouraged to monitor potassium levels in the serum.

Storage conditions

List B. In a temperature not exceeding 30 ° C (not freezing)

Shelf life

5 years

The registration

015914/01

Of drugs

It expressed bronholiticeski (widening gap bronchi) effect resulting from the operation of the product components ipratropia bromide and fenoterola with different mechanisms and containment action. Fenoterol has bronchodilatory effect, bringing beta2-adrainoretseptora bronchi, ipratropia bromide eliminates holinergicakie impact on the smooth musculature bronchi. The combined use of these drugs increases the efficiency bronchodilating therapy in a variety of diseases with a raise of bronchial tone muscles, and allows them to lower doses.

Indications for use

Supportive therapy and prevention of respiratory failure in obstruguom chronic bronchitis (bronchial pneumonia, goes violating vehicles on the air), amfizematosnom bronchitis (bronchial pneumonia, accompanying vozdushnosti increase and the decline of lung function fabrics), bronholegochnykh disease to the presence of bronchospasm (a sharp narrow clearance bronchi), hypersensitivity bronchi. Systematic and episodic treatment of acute attacks of asthma. The respiratory tract to the aerosol medication : antibiotics, mukoliticakih (razzyzath sputum) funds Corticosteroids (cortex hormones napochechnikov or their synthetic analogues).

Dosing and Administration

Dose aerosol adults and children over 3 years of age are usually appoint 1-2 aerosol dose three times a day. Where there are threats of respiratory failure-2 16e15 doses of the spray, if necessary in five minutes, the other two doses up ingalatia hold no less than 2 hours Mortar for inhalations : normal dose of 2-8 drops (0.1-0.4 ml) 3-6 times a day at intervals of not less than 2 hours Using elektroraspalitel-4 drops in the dispenser from 3 ml izotoniceski solution of sodium chloride (or other fluids), inhaled 5-7 minutes before making full use of the solution; In the use of hand-held spray-20-30 breaths vanish solution. The simultaneous use of the drug and intalom korticosteroidami contributing preparation.

Side-Effects

Brown mouth, the ccomodation (of the visual perception), tremor (shaking) fingers, ucaschenne heartbeat, glaucoma (increased pressure vnutriglaznogo) tahiaritmia (ucaschenne neritmicnae heart).

Form of

Dose aerosol inhalations for (1 dose -0,00002 g ipratropia bromide and 0.00005 grams fenoterola hydrobromide); SOLUTION inhalations (1 ml - 0.00025 grams ipratropia bromide and 0.0005 g fenoterola hydrobromide), in bottles of 20 ml.

All products of this group

0